对巴塞罗那磁共振成像（MRI）预测模型和Proclarix进行排序以改善不确定的前列腺影像报告和数据系统（PI-RADS）3类情况。 - Suppr

Sequencing the Barcelona-MRI predictive model and Proclarix for improving the uncertain PI-RADS 3.

作者信息

Morote Juan, Celma Ana, Méndez Olga, Trilla Enrique

机构信息

Department of Surgery Universitat Autònoma de Barcelona Bellaterra Spain.

Department of Urology Vall d'Hebron University Hospital Barcelona Spain.

出版信息

BJUI Compass. 2024 Oct 22;5(12):1252-1254. doi: 10.1002/bco2.448. eCollection 2024 Dec.

DOI:10.1002/bco2.448

PMID:39744069

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11685173/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/076c/11685173/720b5454e382/BCO2-5-1252-g001.jpg

相似文献

Sequencing the Barcelona-MRI predictive model and Proclarix for improving the uncertain PI-RADS 3.

BJUI Compass. 2024 Oct 22;5(12):1252-1254. doi: 10.1002/bco2.448. eCollection 2024 Dec.

Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI.

Cancers (Basel). 2022 May 30;14(11):2702. doi: 10.3390/cancers14112702.

Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 Category.

Eur Urol Open Sci. 2022 Jan 23;37:38-44. doi: 10.1016/j.euros.2021.12.009. eCollection 2022 Mar.

Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging.

BJU Int. 2023 Aug;132(2):188-195. doi: 10.1111/bju.15998. Epub 2023 Mar 21.

Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?

Int J Biol Markers. 2022 Jun;37(2):218-223. doi: 10.1177/03936155221081537. Epub 2022 Feb 24.

Evaluation of Proclarix in the diagnostic work-up of prostate cancer.

BJUI Compass. 2023 Sep 29;5(2):297-303. doi: 10.1002/bco2.293. eCollection 2024 Mar.

The Barcelona Predictive Model of Clinically Significant Prostate Cancer.

Cancers (Basel). 2022 Mar 21;14(6):1589. doi: 10.3390/cancers14061589.

Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer.

Eur Urol Open Sci. 2023 May 22;53:46-54. doi: 10.1016/j.euros.2023.03.013. eCollection 2023 Jul.

Validation of the Barcelona-MRI predictive model when PI-RADS v2.1 is used with trans-perineal prostate biopsies.

Int Braz J Urol. 2024 Sep-Oct;50(5):595-604. doi: 10.1590/S1677-5538.IBJU.2024.0204.

Added value of amide proton transfer-weighted magnetic resonance imaging to Prostate Imaging Reporting and Data System version 2.1 in differentiating clinically significant prostate cancer.

Quant Imaging Med Surg. 2024 Dec 5;14(12):9036-9048. doi: 10.21037/qims-24-1121. Epub 2024 Nov 29.

本文引用的文献

Reducing the demand for magnetic resonance imaging scans and prostate biopsies during the early detection of clinically significant prostate cancer: Applying the Barcelona risk-stratified pathway in Catalonia.

Urol Oncol. 2024 Apr;42(4):115.e1-115.e7. doi: 10.1016/j.urolonc.2023.09.020. Epub 2024 Feb 10.

Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-U.

Eur Urol. 2023 Dec;84(6):519-522. doi: 10.1016/j.eururo.2023.08.002. Epub 2023 Sep 12.

A risk-organised model for clinically significant prostate cancer early detection.

BJUI Compass. 2023 Mar 7;4(4):420-422. doi: 10.1002/bco2.230. eCollection 2023 Jul.

Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI.

Cancers (Basel). 2022 May 30;14(11):2702. doi: 10.3390/cancers14112702.

Cancer detection rates of the PI-RADSv2.1 assessment categories: systematic review and meta-analysis on lesion level and patient level.

Prostate Cancer Prostatic Dis. 2022 Feb;25(2):256-263. doi: 10.1038/s41391-021-00417-1. Epub 2021 Jul 6.

Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.

Eur Urol Oncol. 2021 Oct;4(5):697-713. doi: 10.1016/j.euo.2020.12.004. Epub 2020 Dec 25.

Prostate Imaging Reporting and Data System 3 Category Cases at Multiparametric Magnetic Resonance for Prostate Cancer: A Systematic Review and Meta-analysis.

Eur Urol Focus. 2020 May 15;6(3):463-478. doi: 10.1016/j.euf.2019.06.014. Epub 2019 Jul 4.

MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?

Transl Androl Urol. 2018 Feb;7(1):70-82. doi: 10.21037/tau.2017.12.31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Sequencing the Barcelona-MRI predictive model and Proclarix for improving the uncertain PI-RADS 3.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献